Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice

Psychoneuroendocrinology

Volumn 42, Issue , 2014, Pages 225-236

  Peters, Sebastian ^a   Slattery, David A ^a   Uschold Schmidt, Nicole ^a   Reber, Stefan O ^a,b   Neumann, Inga D ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Anxiety; Chronic subordinate colony housing; Oxytocin; Receptor binding

Indexed keywords

MESSENGER RNA; OXYTOCIN; OXYTOCIN RECEPTOR;

ADRENAL DISEASE; ADRENAL HYPERTROPHY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BASOLATERAL AMYGDALA; CHRONIC DRUG ADMINISTRATION; CHRONIC STRESS; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; IN VITRO STUDY; MALE; MEDIAL AMYGDALA; MEDIAN RAPHE NUCLEUS; MENTAL STRESS; MOUSE; NEUROPROTECTION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RECEPTOR BINDING; SENSITIVITY ANALYSIS; SEPTUM PELLUCIDUM; THYMUS ATROPHY;

ANXIETY; CHRONIC SUBORDINATE COLONY HOUSING; OXYTOCIN; RECEPTOR BINDING;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; OXYTOCIN; RECEPTORS, OXYTOCIN; STRESS, PSYCHOLOGICAL;

EID: 84895876344     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.01.021     Document Type: Article

References (66)

1. Amico J.A., Mantella R.C., Vollmer R.R., Li X. Anxiety and stress responses in female oxytocin deficient mice. J. Neuroendocrinol. 2004, 16:319-324.
2. Bale T.L., Davis A.M., Auger A.P., Dorsa D.M., McCarthy M.M. CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J. Neurosci. 2001, 21:2546-2552.
3. Bales K.L., Perkeybile A.M., Conley O.G., Lee M.H., Guoynes C.D., Downing G.M., Yun C.R., Solomon M., Jacob S., Mendoza S.P. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biol. Psychiatry 2012, 74:180-188.
4. Bartlang M.S., Neumann I.D., Slattery D.A., Uschold-Schmidt N., Kraus D., Helfrich-Forster C., Reber S.O. Time matters: pathological effects of repeated psychosocial stress during the active, but not inactive, phase of male mice. J. Endocrinol. 2012, 215:425-437.
5. Bartolomucci A., Palanza P., Sacerdote P., Ceresini G., Chirieleison A., Panerai A.E., Parmigiani S. Individual housing induces altered immuno-endocrine responses to psychological stress in male mice. Psychoneuroendocrinology 2003, 28:540-558.
6. Berton O., Aguerre S., Sarrieau A., Mormede P., Chaouloff F. Differential effects of social stress on central serotonergic activity and emotional reactivity in Lewis and spontaneously hypertensive rats. Neuroscience 1998, 82:147-159.
7. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
8. Blevins J.E., Ho J.M. Role of oxytocin signaling in the regulation of body weight. Rev. Endocr. Metab. Disord. 2013, 14:311-329.
9. Blume A., Bosch O.J., Miklos S., Torner L., Wales L., Waldherr M., Neumann I.D. Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur. J. Neurosci. 2008, 27:1947-1956.
10. Caughey S.D., Klampfl S.M., Bishop V.R., Pfoertsch J., Neumann I.D., Bosch O.J., Meddle S.L. Changes in the intensity of maternal aggression and central oxytocin and vasopressin V1a receptors across the peripartum period in the rat. J. Neuroendocrinol. 2011, 23:1113-1124.
11. Chourbaji S., Zacher C., Sanchis-Segura C., Spanagel R., Gass P. Social and structural housing conditions influence the development of a depressive-like phenotype in the learned helplessness paradigm in male mice. Behav. Brain Res. 2005, 164:100-106.
12. Conti F., Sertic S., Reversi A., Chini B. Intracellular traffickingof the human oxytocin receptor: evidence of oxytocin receptor recycling via a Rab4/Rab5 "short cycle". Am. J. Physiol. Endocrinol. Metab. 2009, 296:E532-E542.
13. Detillion C.E., Craft T.K., Glasper E.R., Prendergast B.J., DeVries A.C. Social facilitation of wound healing. Psychoneuroendocrinology 2004, 29:1004-1011.
14. Donaldson Z.R., Young L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008, 322:900-904.
15. Duffy L.C., Zielezny M.A., Marshall J.R., Byers T.E., Weiser M.M., Phillips J.F., Calkins B.M., Ogra P.L., Graham S. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav. Med. 1991, 17:101-110.
16. Engler H., Stefanski V. Social stress and T cell maturation in male rats: transient and persistent alterations in thymic function. Psychoneuroendocrinology 2003, 28:951-969.
17. Feifel D., Macdonald K., Nguyen A., Cobb P., Warlan H., Galangue B., Minassian A., Becker O., Cooper J., Perry W., Lefebvre M., Gonzales J., Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol. Psychiatry 2010, 68:678-680.
18. Gasparotto O.C., Lopes D.M., Carobrez S.G. Pair housing affects anxiety-like behaviors induced by a social but not by a physiological stressor in male Swiss mice. Physiol. Behav. 2005, 85:603-612.
19. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
20. Griebel G., Holsboer F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?. Nat. Rev. Drug Discovery 2012, 11:462-478.
21. Grippo A.J., Pournajafi-Nazarloo H., Sanzenbacher L., Trahanas D.M., McNeal N., Clarke D.A., Porges S.W., Sue Carter C. Peripheral oxytocin administration buffers autonomic but not behavioral responses to environmental stressors in isolated prairie voles. Stress 2012, 15:149-161.
22. Grippo A.J., Trahanas D.M., Zimmerman R.R., Porges S.W., Carter C.S. Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology 2009, 34:1542-1553.
23. Guastella A.J., Howard A.L., Dadds M.R., Mitchell P., Carson D.S. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 2009, 34:917-923.
24. Guzman Y.F., Tronson N.C., Jovasevic V., Sato K., Guedea A.L., Mizukami H., Nishimori K., Radulovic J. Fear-enhancing effects of septal oxytocin receptors. Nat. Neurosci. 2013, 16:1185-1187.
25. Heinrichs M., Baumgartner T., Kirschbaum C., Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 2003, 54:1389-1398.
26. Heinrichs M., Meinlschmidt G., Neumann I., Wagner S., Kirschbaum C., Ehlert U., Hellhammer D.H. Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. J. Clin. Endocrinol. Metab. 2001, 86:4798-4804.
27. Hillerer K.M., Reber S.O., Neumann I.D., Slattery D.A. Exposure to chronic pregnancy stress reverses peripartum-associated adaptations: implications for postpartum anxiety and mood disorders. Endocrinology 2011, 152:3930-3940.
28. Huang H., Michetti C., Busnelli M., Manago F., Sannino S., Scheggia D., Giancardo L., Sona D., Murino V., Chini B., Scattoni M.L., Papaleo F. Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology 2013, 10.1038/npp.2013.310.
29. Jurek B., Slattery D.A., Maloumby R., Hillerer K., Koszinowski S., Neumann I.D., van den Burg E.H. Differential contribution of hypothalamic MAPK activity to anxiety-like behaviour in virgin and lactating rats. PLoS One 2012, 7:e37060.
30. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., Gruppe H., Mattay V.S., Gallhofer B., Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 2005, 25:11489-11493.
31. Knobloch H.S., Charlet A., Hoffmann L.C., Eliava M., Khrulev S., Cetin A.H., Osten P., Schwarz M.K., Seeburg P.H., Stoop R., Grinevich V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012, 73:553-566.
32. Levenstein S., Prantera C., Varvo V., Scribano M.L., Andreoli A., Luzi C., Arca M., Berto E., Milite G., Marcheggiano A. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am. J. Gastroenterol. 2000, 95:1213-1220.
33. Litvin Y., Murakami G., Pfaff D.W. Effects of chronic social defeat on behavioral and neural correlates of sociality: vasopressin, oxytocin and the vasopressinergic V1b receptor. Physiol. Behav. 2011, 103:393-403.
34. Lukas M., Bredewold R., Neumann I.D., Veenema A.H. Maternal separation interferes with developmental changes in brain vasopressin and oxytocin receptor binding in male rats. Neuropharmacology 2010, 58:78-87.
35. Lukas M., Neumann I.D. Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders. Behav. Brain Res. 2013, 251:85-94.
36. Lukas M., Toth I., Reber S.O., Slattery D.A., Veenema A.H., Neumann I.D. The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology 2011, 36:2159-2168.
37. Macdonald K., Feifel D. Oxytocin in schizophrenia: a review of evidence for its therapeutic effects. Acta Neuropsychiatr. 2012, 24:130-146.
38. Mak P., Broussard C., Vacy K., Broadbear J.H. Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. J. Psychopharmacol. 2012, 26:532-542.
39. Mantella R.C., Vollmer R.R., Li X., Amico J.A. Female oxytocin-deficient mice display enhanced anxiety-related behavior. Endocrinology 2003, 144:2291-2296.
40. Meyer-Lindenberg A., Domes G., Kirsch P., Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci. 2011, 12:524-538.
41. Neumann I.D., Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 2012, 35:649-659.
42. Neumann I.D., Wigger A., Torner L., Holsboer F., Landgraf R. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. J. Neuroendocrinol. 2000, 12:235-243.
43. Paxinos, G., Franklin, K.B.J., 1997. The mouse brain in stereotaxic coordinate, San Diego, California.
44. Peters S., Grunwald N., Rummele P., Endlicher E., Lechner A., Neumann I.D., Obermeier F., Reber S.O. Chronic psychosocial stress increases the risk for inflammation-related colon carcinogenesis in male mice. Stress 2012, 15:403-415.
45. Peters S., Slattery D.A., Flor P.J., Neumann I.D., Reber S.O. Differential effects of baclofen and oxytocin on the increased ethanol consumption following chronic psychosocial stress in mice. Addict. Biol. 2013, 18:66-77.
46. Reber S.O., Birkeneder L., Veenema A.H., Obermeier F., Falk W., Straub R.H., Neumann I.D. Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: implications and mechanisms. Endocrinology 2007, 148:670-682.
47. Reber S.O., Neumann I.D. Defensive behavioral strategies and enhanced state anxiety during chronic subordinate colony housing are accompanied by reduced hypothalamic vasopressin, but not oxytocin, expression. Ann. N.Y. Acad. Sci. 2008, 1148:184-195.
48. Reber S.O., Obermeier F., Straub R.H., Veenema A.H., Neumann I.D. Aggravation of DSS-induced colitis after chronic subordinate colony (CSC) housing is partially mediated by adrenal mechanisms. Stress 2008, 11:225-234.
49. Reber S.O., Peters S., Slattery D.A., Hofmann C., Scholmerich J., Neumann I.D., Obermeier F. Mucosal immunosuppression and epithelial barrier defects are key events in murine psychosocial stress-induced colitis. Brain Behav. Immun. 2011, 25:1153-1161.
50. Reiche E.M., Nunes S.O., Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004, 5:617-625.
51. Sala M., Braida D., Lentini D., Busnelli M., Bulgheroni E., Capurro V., Finardi A., Donzelli A., Pattini L., Rubino T., Parolaro D., Nishimori K., Parenti M., Chini B. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 2011, 69:875-882.
52. Schmidt M.V., Scharf S.H., Liebl C., Harbich D., Mayer B., Holsboer F., Muller M.B. A novel chronic social stress paradigm in female mice. Horm. Behav. 2010, 57:415-420.
53. Shalev A.Y. Posttraumatic stress disorder and stress-related disorders. Psychiatr. Clin. North Am. 2009, 32:687-704.
54. Singewald G.M., Nguyen N.K., Neumann I.D., Singewald N., Reber S.O. Effect of chronic psychosocial stress-induced by subordinate colony (CSC) housing on brain neuronal activity patterns in mice. Stress 2009, 12:58-69.
55. Slattery D.A., Neumann I.D. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61.
56. Slattery D.A., Neumann I.D. Oxytocin and major depressive disorder: experimental and clinical evidence for links to aetiology and possible treatment. Pharmaceuticals 2010, 3:702-724.
57. Slattery D.A., Uschold N., Magoni M., Bar J., Popoli M., Neumann I.D., Reber S.O. Behavioural consequences of two chronic psychosocial stress paradigms: anxiety without depression. Psychoneuroendocrinology 2012, 37:702-714.
58. Smith A.S., Wang Z. Hypothalamic oxytocin mediates social buffering of the stress response. Biol. Psychiatry 2013, 10.1016/j.biopsych.2013.09.017.
59. Stefanski V., Knopf G., Schulz S. Long-term colony housing in Long Evans rats: immunological, hormonal, and behavioral consequences. J. Neuroimmunol. 2001, 114:122-130.
60. Uschold-Schmidt N., Nyuyki K.D., Fuchsl A.M., Neumann I.D., Reber S.O. Chronic psychosocial stress results in sensitization of the HPA axis to acute heterotypic stressors despite a reduction of adrenal in vitro ACTH responsiveness. Psychoneuroendocrinology 2012, 37:1676-1687.
61. Viviani D., Charlet A., van den Burg E., Robinet C., Hurni N., Abatis M., Magara F., Stoop R. Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 2011, 333:104-107.
62. Waldherr M., Neumann I.D. Centrally released oxytocin mediates mating-induced anxiolysis in male rats. PNAS 2007, 104:16681-16684.
63. Windle R.J., Kershaw Y.M., Shanks N., Wood S.A., Lightman S.L., Ingram C.D. Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J. Neurosci. 2004, 24:2974-2982.
64. Windle R.J., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997, 138:2829-2834.
65. Yoshida M., Takayanagi Y., Inoue K., Kimura T., Young L.J., Onaka T., Nishimori K. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci. 2009, 29:2259-2271.
66. Zanos P., Georgiou P., Wright S.R., Hourani S.M., Kitchen I., Winsky-Sommerer R., Bailey A. The oxytocin analouge carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice. Neuropsychopharmacology. 2013, 10.1038/npp.2013.285.